- Initial clinical data from the Phase 1/2 CX-072 program to be reported at ...
SAN DIEGO, July 03, 2018 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced ...
Shire Receives U.S. FDA Approval for New State-of-the-Art Plasma Manufacturing Facility Near Covington, Georgia ...
